Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
26 hedge funds and large institutions have $1.27M invested in Reunion Neuroscience Inc. Common Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
4% less funds holding
Funds holding: 27 → 26 (-1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
41% less capital invested
Capital invested by funds: $2.15M → $1.27M (-$875K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$29.3K |
| 2 |
LPL Financial
San Diego,
California
|
+$14.9K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$1.68K |
| 4 |
Jane Street
New York
|
+$1.64K |
| 5 |
CCA
Column Capital Advisors
Indianapolis,
Indiana
|
+$248 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$71.3K |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$50.9K |
| 3 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
-$16K |
| 4 |
Millennium Management
New York
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.59K |
REUN Hedge Fund Activity: Q4 2022 in Review
26 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q4 2022, worth a combined $1.27M — down 41% from $2.15M a quarter earlier.
Fund positioning in REUN was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 6 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $29.3K. The largest seller was DAFNA Capital Management, cutting an estimated $71.3K.
- 26 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q4 2022, down from 27 in Q3 2022.
- Funds reported $1.27M of Reunion Neuroscience Inc. Common Shares stock for Q4 2022, down 41% quarter-over-quarter.
- 2 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Reunion Neuroscience Inc. Common Shares buyer in Q4 2022 was AdvisorShares Investments, an estimated $29.3K added.
- The largest Reunion Neuroscience Inc. Common Shares seller in Q4 2022 was DAFNA Capital Management, an estimated $71.3K sold.
Based on aggregated 13F filings for Q4 2022.